following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). .
cancer patients� lives are being put at risk because savage tory cuts to the nhs are delaying the start of their treatment by 18 months. .